Lilly Telegraphs $126M Japan Production Expansion
12 Mar 2026 //
FIERCE PHARMA
Lilly Finds Impurity in Compounded Version of Weight-loss Drug
12 Mar 2026 //
REUTERS
Lilly Shines In Q4 As Peers Brace For 2026 Slowdown
12 Mar 2026 //
FIERCE PHARMA
Lilly Pumps $3B Into China To Boost Supply Of Weight Loss Pill
12 Mar 2026 //
BIOSPACE
Andel Introduces Direct-To-Employer Medication Platform
11 Mar 2026 //
PR NEWSWIRE
Lilly pledges $500M to South Korea biopharma industry
11 Mar 2026 //
FIERCE BIOTECH
Lilly Pledges $500M To South Korea Biopharma Industry
10 Mar 2026 //
FIERCE BIOTECH
Lilly CEO Ricks Collects $36.7 Million Pay Package For 2025
09 Mar 2026 //
FIERCE PHARMA
Eli Lilly Launches Its Direct-To-Employer Platform For Glp-1s
05 Mar 2026 //
FIERCE PHARMA
Eli Lilly on Track to Launch Oral Obesity Drug in 2nd Quarter
05 Mar 2026 //
REUTERS
Keytruda Hangs On To Best Seller Crown As Glp-1s Gain Ground
04 Mar 2026 //
BIOSPACE
IMPACT-O Study Reveals Deficiencies In Overweight And Obesity
03 Mar 2026 //
PHARMIWEB
Eli Lilly Holds Premium Price Ahead of Generic Rivals
02 Mar 2026 //
ECONOMICTIMES
CHMP Recommends Lilly’s Olumiant for Teen Alopecia Areata in EU
27 Feb 2026 //
PR NEWSWIRE
Lilly Debuts Nvidia Supercomputer With Fanfare And Focus
27 Feb 2026 //
FIERCE PHARMA
Lilly`s Orforglipron Beats Semaglutide in Type 2 Diabetes Trial
26 Feb 2026 //
PR NEWSWIRE
Lilly Tops Novo In Weight Loss Again, This Time On The Oral Front
26 Feb 2026 //
BIOSPACE
Eli Lilly India Launches Obesity Awareness Campaign
26 Feb 2026 //
EXPRESSPHARMA
Lilly to Launch Multi-Dose Weight-Loss Drug Device in US
24 Feb 2026 //
REUTERS
NHI Appoints Lilly H. Donohue To Board Of Directors
23 Feb 2026 //
PHARMIWEB
Lilly Adds Multidose Zepbound Pens To Self-Pay Menu
23 Feb 2026 //
FIERCE PHARMA
Lilly`s Taltz And Zepbound Show Superior Efficacy In Psoriasis
19 Feb 2026 //
PR NEWSWIRE
Hope For The Warriors Awarded $3M Grant from Lilly Endowment
18 Feb 2026 //
PHARMIWEB
Lilly And Shaq Join Team Usa`s Olympic Athlete Recovery Program
18 Feb 2026 //
FIERCE PHARMA
Eli Lilly Eyes India as Mounjaro Export Hub
17 Feb 2026 //
ECONOMICTIMES
CSL Signs Licensing Deal with Eli Lilly for Clazakizumab
17 Feb 2026 //
REUTERS
USOPC Announces Team Athlete Recovery Program Partner with Eli
16 Feb 2026 //
PR NEWSWIRE
Lilly To Participate In TD Cowen`s 46th Annual Health Care
16 Feb 2026 //
PR NEWSWIRE
Lilly`s Retevmo Delivers Substantial Event-Free Survival Benefit
16 Feb 2026 //
PR NEWSWIRE
Lilly Preps $1B+ Orforglipron as Novo Ships Wegovy Abroad
13 Feb 2026 //
BIOSPACE
Lilly Builds Sizable Store Of Orforglipron Ahead Of FDA Verdict
13 Feb 2026 //
FIERCE PHARMA
Novo, Lilly Earnings Ignite Weight Loss Drama, Gene Therapy Buzz
11 Feb 2026 //
BIOSPACE
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
Globaldata Reports Dip In Pharma Deal Value In January 2026
09 Feb 2026 //
EXPRESSPHARMA
Eli Lilly Acquires $2.4B Orna For CAR T Entry In Autoimmune
09 Feb 2026 //
PR NEWSWIRE
Innovent And Lilly Partner To Develop Global Oncology
08 Feb 2026 //
PR NEWSWIRE
The Biggest Potential Drug Launches Of 2026
06 Feb 2026 //
FIERCE PHARMA
Lilly Lauds Scientific, Athletic Progress In Winter Olympics Ad
06 Feb 2026 //
FIERCE PHARMA
US Government Launches Trumprx Drug Purchasing Portal
06 Feb 2026 //
FIERCE PHARMA
Lilly`s Orforglipron Rides Wegovy`s Success Wave
04 Feb 2026 //
BIOSPACE
Lilly Unveils Q4 2025 Financial Updates, Offers 2026 Outlook
04 Feb 2026 //
PR NEWSWIRE
Lilly Eyes Pipeline in a Product as GLP-1s Move Into I&I
04 Feb 2026 //
BIOSPACE
Lilly Drops 3 Clinical Programs, Including Prevail Gene Therapy
04 Feb 2026 //
FIERCE BIOTECH
Zonsen Peplib Bio Enters Global R&D Pact With Lilly
03 Feb 2026 //
BUSINESSWIRE
Amgen, Lilly Recommit to Puerto Rico Pharma Revival
03 Feb 2026 //
BIOSPACE
Obesity Market Sales Tightens as Novo & Lilly Enter New Era
02 Feb 2026 //
REUTERS
Lilly Drafts Plan For Last Of 4 New US Drug Manufacturing Plants
01 Feb 2026 //
FIERCE PHARMA
Roche Plans To Go Toe-To-Toe With Novo, Lilly In Obesity
29 Jan 2026 //
BIOSPACE
Repertoire, Lilly Partner on Autoimmune Diseases
29 Jan 2026 //
PR NEWSWIRE
FOIA Lawsuit Targets Trump MFN Pricing Deals With Lilly, Pfizer
28 Jan 2026 //
FIERCE PHARMA
Lilly Pens $1.1B Pact To Work On Hearing Loss Gene Editing Med
28 Jan 2026 //
PRESS RELEASE
Lilly Refocuses Obesity Conversation On Health In Short Film
23 Jan 2026 //
FIERCE PHARMA
Wegovy Pill Launch Wows With Strong Early Uptake: Analysts
23 Jan 2026 //
FIERCE PHARMA
Lilly Sets Date For Q4 2025 Financial Results Call
21 Jan 2026 //
PR NEWSWIRE
Biocom Unveils Keynote Panel With Abbvie, Amgen, Eli Lilly Heads
21 Jan 2026 //
BUSINESSWIRE
Biohaven Prepares To Challenge Lilly After Tough 2025
20 Jan 2026 //
BIOSPACE
FDA Grants Breakthrough Designation to Lilly`s Sofetabart
20 Jan 2026 //
PR NEWSWIRE
4 Next-Gen Candidates That Could Form the Future of Alzheimer
19 Jan 2026 //
BIOSPACE
Four Next-Gen Candidates Shape Alzheimer`s Future
19 Jan 2026 //
BIOSPACE
FDA Delays Decision On Lilly`s Obesity Drug Orforglipron
17 Jan 2026 //
REUTERS

Market Place
Sourcing Support